MedPath

Treatment for menstrual period problems by panchakarma therapy and ayurvedic medicine

Phase 2
Completed
Conditions
Disorder of carbohydrate metabolism, unspecified. Ayurveda Condition: Aartava kshaya, PCOS DIAGNOSED CASES OF AGE GROUP 20 TO 40 YRS WHICH ARE FIT FOR VAMANA AND BASTIKARMA,
Registration Number
CTRI/2017/02/007825
Lead Sponsor
National Institute of Ayurveda
Brief Summary

This study is a randomised open labelled parallel group comparing effect of *Vamana karma* (therapeutic emesis)  and *Basti karma* (medicated enema) followed by *Shatapushpadi Ghanawati* in both the groups for 45 days in 30 patients (15 patients in each group) of polycystic ovarian syndrome is conducting in National Institute of Ayurveda in India.

*Vamana karma* is a *shodhana* therapy  in which*Snehapana* with *Murchita tila taila* followed by *Vamana* procedure by *Ikshwaku beeja choorna* yoga given as per standard Panchakarma protocol according to patient`s *Agni* and *Koshtha stithi* till *Samyaka shudhi lakshana* will be acheived.

*Basti karma* with *Bhadradi kaphanashaka basti* in*Kala basti* schedule ( 16days) ,initially 2 *Aanuvasana basti* with *Sarshapa* oil followed by alternate*Aanuvasana*(Medicated oil enema) and N*iruha*(decoction enema) combination followed by A*anuwasana basti* (medicated oil enema) at the end.

The primary outcome measures are regulation of normal menstrual pattern and assesment of disease condition including factors like obesity, hirsutism etc after 60 days of treatment. The secondary outcome is regulation of normal menstrual pattern and assesment of PCOS related complications at 15 days and 60 days.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
30
Inclusion Criteria

1 Age group 20 to 40 yrs both unmarried and married patients 2 PCOS diagnosed cases by revised rotterdam criteria 3 Irregular menses scanty menses due to anovulatory cycle 4 Patient fit for Vamana and Bastikarma.

Exclusion Criteria

1 Cervical tumor polyp Ca cervix 2 Uterine fibroid 3 Congenital anomalies in female genital tract 4 Tubercular endometritis 5 Congenital adrenal hyperplasia 6 HIV VDRL HbsAg positive 7 Malignant disease and patients on cytotoxic drugs 8 Patient not fit for Vamana and Bastikarma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
regulation of normal menstrual pattern and assesment of disease condition including factors like obesity hirsutism etc60 DAYS
Secondary Outcome Measures
NameTimeMethod
regulation of normal menstrual pattern and assesment of PCOS related complications.15 DAYS 60 DAYS

Trial Locations

Locations (1)

National Institute of Ayurveda

🇮🇳

Jaipur, RAJASTHAN, India

National Institute of Ayurveda
🇮🇳Jaipur, RAJASTHAN, India
Dr Bhingardive Kamini Balasaheb
Principal investigator
07877736643
drkamini111@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.